Home › Stocks › LIMN

LIMN — LIMINATUS PHARMA INC.

Reported value held$453.14K
Funds holding (latest)29
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)10
Institutional value$231.37K · 62.02K sh
New / Add / Cut / Exit4 / 1 / 5 / 8 · Updated 2026-11-16
Top-5 / Top-10 concentration97.2% / 100.0%
Institutional holdings change Reducing -81.0% (-191.08K sh)
Institutional value change Up +543.7%

Fundamentals (SEC EDGAR XBRL)

Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.

Revenue TTM Revenue YoY Net income TTM Net income YoY ROE (TTM) Gross margin Net margin P/E (TTM) P/E pct P/B P/B pct
— — — — — — — — — — —

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 10 SEC-registered investment managers reported holding LIMN (LIMINATUS PHARMA INC.) in their latest 13F filings, with a combined reported value of $231.37K across 62.02K shares. That is -81.0% by share count (-191.08K shares) versus the previous quarter, while reported value moved +543.7%. Ownership is concentrated: the five largest holders account for 97.2% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 4 opened new positions, 1 added to existing stakes, 5 trimmed, 8 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of LIMINATUS PHARMA INC. (LIMN) include Geode Capital Management, JANE STREET GROUP, LLC, Vanguard Group, ranked by reported 13F value among the 29 institutional holders on this page.

LIMN is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 10 62.02K $231.37K -81.0%
Q2 2026 14 1.07M $118.28K -52.2%
Q1 2026 15 1.48M $253.76K +340.7%
Q4 2025 12 317.19K $193.50K -6.0%
Q3 2025 10 261.92K $437.44K +5.1%
Q2 2025 10 204.70K $2.28M —

Over the 6 quarters shown, institutional share counts decreased 70% in aggregate (Q2 2025 → Q3 2026); the largest single-quarter swing was Q1 2026 (+340.7%).

Top Institutional Holders (Q3 2026) — 10 funds

FundSharesValuePortfolio WeightChange
Geode Capital Management 41.21K $153.70K 0.00% Reduce
JANE STREET GROUP, LLC 14.95K $55.76K 0.00% New
Morgan Stanley 1.94K $7.22K 0.00% New
UBS Group AG 1.20K $4.48K 0.00% Reduce
VANGUARD CAPITAL MANAGEMENT LLC 1.01K $3.76K 0.00% Reduce
BlackRock Inc 934 $3.48K 0.00% Add
VANGUARD FIDUCIARY TRUST CO 460 $1.72K 0.00% Reduce
JPMorgan Chase & Co 137 $536 0.00% New
Cheviot Value Management, LLC 100 $373 0.00% New
Tower Research Capital LLC (TRC) 87 $325 0.00% Reduce

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 14 funds

FundSharesValuePortfolio WeightChange
Cygnus Capital Advisors, LLC 329.33K $36.00K 0.03% Reduce
XTX Topco Ltd 221.84K $24.49K 0.00% New
GEODE CAPITAL MANAGEMENT, LLC 138.42K $15.28K 0.00% New
Geode Capital Management 138.42K $15.28K 0.00% Add
Citadel Advisors 56.09K $6.19K 0.00% Reduce
VANGUARD CAPITAL MANAGEMENT LLC 50.44K $5.55K 0.00% Hold
Goldman Sachs Group 40.22K $4.44K 0.00% New
StoneX Group Inc. 26.06K $3.93K 0.00% New
VANGUARD FIDUCIARY TRUST CO 22.98K $2.53K 0.00% Hold
UBS Group AG 16.73K $1.84K 0.00% Reduce
Vanguard Personalized Indexing Management, LLC 13.15K $1.45K 0.00% Reduce
Tower Research Capital LLC (TRC) 7.09K $783 0.00% Reduce
BARCLAYS PLC 4.29K $474 0.00% New
BlackRock Inc 313 $35 0.00% Reduce

Q1 2026 — 15 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 677.52K $116.47K 0.00% Add
Cygnus Capital Advisors, LLC 350.00K $60.00K 0.06% New
Geode Capital Management 117.78K $20.25K 0.00% Add
JANE STREET GROUP, LLC 71.32K $12.26K 0.00% New
UBS Group AG 54.58K $9.39K 0.00% Add
VANGUARD CAPITAL MANAGEMENT LLC 50.44K $8.68K 0.00% New
Vanguard Personalized Indexing Management, LLC 34.71K $5.97K 0.00% New
Virtu Financial LLC 27.47K $5.00K 0.00% New
VANGUARD FIDUCIARY TRUST CO 22.98K $3.95K 0.00% New
TWO SIGMA SECURITIES, LLC 22.04K $3.79K 0.00% Add
STATE STREET CORP 19.00K $3.27K 0.00% Hold
BlackRock Inc 13.25K $2.28K 0.00% Hold
Tower Research Capital LLC (TRC) 7.57K $1.30K 0.00% Reduce
Citigroup Inc 6.77K $1.16K 0.00% Add
Farther Finance Advisors, LLC 14 $2 0.00% Reduce

Q4 2025 — 12 funds

FundSharesValuePortfolio WeightChange
Vanguard Group 73.42K $44.79K 0.00% Hold
Citadel Advisors 70.93K $43.27K 0.00% New
Geode Capital Management 65.05K $39.69K 0.00% Add
Two Sigma Investments 35.28K $21.52K 0.00% New
UBS Group AG 19.39K $11.83K 0.00% Reduce
STATE STREET CORP 19.00K $11.59K 0.00% Hold
BlackRock Inc 13.26K $8.09K 0.00% Hold
TWO SIGMA SECURITIES, LLC 11.88K $7.24K 0.00% New
Tower Research Capital LLC (TRC) 8.90K $5.43K 0.00% Add
Bank of America Corp 44 $27 0.00% Reduce
Farther Finance Advisors, LLC 31 $19 0.00% Hold
Citigroup Inc 1 $1 0.00% New

Q3 2025 — 10 funds

FundSharesValuePortfolio WeightChange
Vanguard Group 73.42K $122.62K 0.00% Hold
Geode Capital Management 63.73K $106.47K 0.00% Hold
UBS Group AG 40.53K $67.68K 0.00% Add
JANE STREET GROUP, LLC 39.63K $66.19K 0.00% New
STATE STREET CORP 19.00K $31.73K 0.00% Hold
BlackRock Inc 13.26K $22.14K 0.00% Hold
Squarepoint Ops LLC 10.40K $17.37K 0.00% New
Tower Research Capital LLC (TRC) 1.85K $3.09K 0.00% Add
Bank of America Corp 68 $113 0.00% Add
Farther Finance Advisors, LLC 31 $52 0.00% New

Q2 2025 — 10 funds

FundSharesValuePortfolio WeightChange
Vanguard Group 73.42K $818.68K 0.00% New
Geode Capital Management 63.84K $711.83K 0.00% New
UBS Group AG 31.49K $351.07K 0.00% New
STATE STREET CORP 19.00K $211.85K 0.00% New
BlackRock Inc 13.26K $147.79K 0.00% New
ROYAL BANK OF CANADA 2.89K $32.00K 0.00% New
Tower Research Capital LLC (TRC) 508 $5.66K 0.00% New
BARCLAYS PLC 184 $2.05K 0.00% New
Bank of America Corp 66 $735 0.00% New
SBI Securities Co., Ltd. 52 $580 0.00% New

View all 29 fund holders →

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Geode Capital Management 41.21K 138.42K 117.78K 65.05K 63.73K 63.84K
JANE STREET GROUP, LLC 14.95K — 71.32K — 39.63K —
Morgan Stanley 1.94K — — — — —
UBS Group AG 1.20K 16.73K 54.58K 19.39K 40.53K 31.49K
VANGUARD CAPITAL MANAGEMENT LLC 1.01K 50.44K 50.44K — — —
BlackRock Inc 934 313 13.25K 13.26K 13.26K 13.26K
VANGUARD FIDUCIARY TRUST CO 460 22.98K 22.98K — — —
JPMorgan Chase & Co 137 — — — — —
Cheviot Value Management, LLC 100 — — — — —
Tower Research Capital LLC (TRC) 87 7.09K 7.57K 8.90K 1.85K 508
Vanguard Group — — — 73.42K 73.42K 73.42K
STATE STREET CORP — — 19.00K 19.00K 19.00K 19.00K
Citadel Advisors — 56.09K 677.52K 70.93K — —
Cygnus Capital Advisors, LLC — 329.33K 350.00K — — —
ROYAL BANK OF CANADA — — — — — 2.89K
XTX Topco Ltd — 221.84K — — — —
Two Sigma Investments — — — 35.28K — —
Squarepoint Ops LLC — — — — 10.40K —
GEODE CAPITAL MANAGEMENT, LLC — 138.42K — — — —
TWO SIGMA SECURITIES, LLC — — 22.04K 11.88K — —

Download holders (CSV)

FAQ

Which funds hold LIMN?

As of 2026-Q3, 10 institutional funds reported holding LIMN (LIMINATUS PHARMA INC.) in SEC 13F filings, with a combined reported value of $231.37K.

How many shares of LIMN do institutions own?

13F filers reported 62.02K shares of LIMN, worth $231.37K in aggregate at the end of 2026-Q3.

Is institutional ownership of LIMN rising or falling?

Share counts moved -81.0% versus the prior quarter — distribution.

Who are the top institutional holders of LIMN?

The largest 13F holders are Geode Capital Management, JANE STREET GROUP, LLC, Vanguard Group, Cygnus Capital Advisors, LLC, ROYAL BANK OF CANADA; the top 25 are ranked at the top of this page.

Who are the major shareholders of LIMINATUS PHARMA INC.?

The major shareholders of LIMINATUS PHARMA INC. (LIMN) by reported 13F value are Geode Capital Management, JANE STREET GROUP, LLC, Vanguard Group, Cygnus Capital Advisors, LLC, ROYAL BANK OF CANADA, among 29 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own LIMN" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/LIMN/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →